October 5, 2022

AndronETalksNews

AndronETalksNews

mRNA vaccine technology moves to flu: Moderna says trial has begun

arstechnica

By

Moderna has given out the first doses of an mRNA-based influenza vaccine to participants in an early-phase clinical trial, the company announced Wednesday.

Moderna ultimately plans to test the vaccine on about 180 people in the Phase 1/2 randomized, stratified, observer-blind trial. The trial will look at safety, different doses, and immune responses.

Read more…

 

Super Sleuth